A new non-invasive test for diagnosing endometriosis in women facing infertility
Performance evaluation of a non-invasive menstrual test for endometriosis in infertility patients
['FUNDING_SBIR_2'] · NEXTGENJANE, INC. · NIH-11185524
This study is working on a simple and non-invasive test using menstrual fluid to help diagnose endometriosis earlier, which could make it easier for women to get the care they need and improve their chances of having children.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEXTGENJANE, INC. (nih funded) |
| Locations | 1 site (Oakland, UNITED STATES) |
| Trial ID | NIH-11185524 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a non-invasive menstrual test to diagnose endometriosis, a condition that often delays diagnosis and negatively impacts fertility. By utilizing menstrual fluid, which contains reproductive tissue, the study aims to create a reliable biomarker test that can be easily collected and transported to a laboratory. This approach seeks to provide earlier detection of endometriosis, potentially improving patient outcomes and reducing the need for invasive surgical procedures. The research is being conducted by NextGen Jane, Inc., which has already shown promising preliminary results with a genomic assay for endometriosis detection.
Who could benefit from this research
Good fit: Ideal candidates for this research are women experiencing infertility who may have endometriosis.
Not a fit: Patients who do not have infertility issues or those who have already been diagnosed with endometriosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of endometriosis, improving fertility outcomes for affected patients.
How similar studies have performed: While the approach of using menstrual fluid for diagnosis is innovative, similar non-invasive diagnostic methods for endometriosis have shown promise in preliminary studies.
Where this research is happening
Oakland, UNITED STATES
- NEXTGENJANE, INC. — Oakland, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GIRE, STEPHEN — NEXTGENJANE, INC.
- Study coordinator: GIRE, STEPHEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.